Avita Medical
(NASDAQ) RCEL
Avita Medical Financials at a Glance
Market Cap
$100.12M
Revenue (TTM)
$72.35M
Net Income (TTM)
-$45.34M
EPS (TTM)
-$1.57
P/E Ratio
-2.57
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Price
$3.87
Volume
120,557.223
Open
$3.99
Price
$3.87
Volume
120,557.223
Open
$3.99
Previous Close
$4.03
Daily Range
$3.84 - $4.06
52-Week Range
$3.22 - $7.12
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Price
$3.87
Volume
120,557.223
Open
$3.99
Previous Close
$4.03
Daily Range
$3.84 - $4.06
52-Week Range
$3.22 - $7.12
Estimated Earnings Date
Aug 6, 2026
RCEL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Avita Medical
Industry
Biotechnology
Sector
Health CareEmployees
226
CEO
Cary Guy Vance, MBA
Website
www.avitamedical.comHeadquarters
Valencia, CA 91355, US
RCEL Financials
Key Financial Metrics (TTM)
Gross Margin
81%
Operating Margin
-55%
Net Income Margin
-63%
Return on Equity
-1746%
Return on Capital
3%
Return on Assets
-88%
Earnings Yield
-38.91%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$100.12M
Shares Outstanding
24.84M
Volume
120.56K
Avg. Volume
238.65K
Financials (TTM)
Gross Profit
$58.82M
Operating Income
-$41.93M
EBITDA
-$39.59M
Operating Cash Flow
-$31.20M
Capital Expenditure
-$1.74M
Free Cash Flow
-$32.93M
Cash & ST Invst.
$18.19M
Total Debt
$46.05M
Avita Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$19.25M
+4.0%
Gross Profit
$15.73M
+0.3%
Gross Margin
81.70%
N/A
Market Cap
$100.12M
N/A
Market Cap/Employee
$431.17K
N/A
Employees
232.2
N/A
Net Income
-$10.61M
+23.4%
EBITDA
-$8.57M
+29.1%
Quarterly Fundamentals
Total Cash
$14.26M
-44.8%
Total Debt
$1.98M
-95.5%
Accounts Receivable
$9.89M
-18.6%
Inventory
$6.12M
-27.1%
Long Term Debt
$3.96M
-91.0%
Short Term Debt
$46.14M
N/A
Return on Assets
-87.96%
N/A
Return on Invested Capital
2.61%
N/A
Free Cash Flow
-$10.09M
+4.3%
Operating Cash Flow
-$10.07M
+2.3%